Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Matrix screen identifies synergistic combination of PARP inhibitors and nicotinamide phosphoribosyltransferase (NAMPT) inhibitors in Ewing Sarcoma
[DOI] [PubMed] [Google Scholar] Gonzlez-Gordo S, Rodrguez-Ruiz M, Lpez-Jaramillo J, Muoz-Vargas MA, Palma JM, Corpas FJ
Safety concerns and counterfeit medications This section could save your health
This potential host mechanism of beneficial enterobactin utilization contributes to the maintenance of iron homeostasis in the host
US modeling by Blue Cross Blue Shield suggests that broad GLP1 coverage could add measurable pressure to employer premiums over the next decade, depending on uptake and duration of therapy
US$ 25.37
US$ 21.20
US$ 26.97
US$ 20.25
US$ 26.58
US$ 28.28
US$ 26.97
US$ 21.27
US$ 25.85
US$ 25.03
US$ 20.69
US$ 21.73
